IGF-1 LR3 1mg
Long-acting IGF-1 analogue with arginine substitution for extended half-life. Researched for muscle growth, tissue repair, and cellular regeneration.
What is IGF1LR3?
IGF-1 LR3 is a long-acting analogue of Insulin-like Growth Factor 1, modified with an arginine substitution (R3) that extends its half-life and stability. It is researched for its potential role in muscle growth, tissue repair, cellular regeneration, and overall performance enhancement.
Key Features
- Extended half-life vs native IGF-1
- Reduced IGF-binding protein affinity
- Well-characterised anabolic signalling pathway
- High purity ≥98% verified by RP-HPLC
Mechanism of Action
IGF-1 LR3 binds to IGF-1 receptors with reduced affinity for IGF-binding proteins, resulting in a prolonged active half-life compared to native IGF-1. It activates PI3K/Akt and MAPK/ERK signalling pathways, promoting cellular proliferation, differentiation, and protein synthesis.
Research Applications
- Lean muscle growth and anabolic signalling research
- Tissue repair and regeneration studies
- Recovery time and training adaptation investigation
- Bone density and connective tissue health research
- Cellular longevity and anti-ageing studies
Reconstitution Guide
Reconstitute with 2ml bacteriostatic water. Store at 2–8°C after reconstitution and use within 28 days.
Research Use Only. For research use only. Not for human or veterinary use. All products are intended solely for in vitro research and laboratory use. Helix Biotech does not endorse, encourage, or condone the use of any research compounds in humans or animals.
Research Tools
Related Products
View all
KLOW 80mg
Advanced research-grade peptide blend synthesised to pharmaceutical purity standards.
CU50 — GHK-Cu 50mg
Copper peptide complex — 50mg tripeptide-copper formulation for tissue and regeneration research.
Epithalon 10mg
Tetrapeptide research compound studied for telomere support and cellular longevity.